In addition, SB100-induced p38 inhibition reduces proinflammatory cytokine production in lung and blood CD8+ cells in COPD patients, while p38 inhibition significantly reduces IFN-γ release from COPD lung-isolated CD8+ cells [23]. Here, MAPK1 is linked to chronic obstructive pulmonary disease.